Auris forms new unit focused on tinnitus and hearing loss
Auris Medical (EARS+12.2%) announces a new subsidiary, Zilentin Ltd., under which it will bundle its development projects in tinnitus (ringing in the ears) and hearing loss. The unit will be domiciled in Zug, Switzerland.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.